References
- World Health Organization. WHO Global Tuberculosis Report 2017. World Health Organization; 2017.
- Eshetie S, Gizachow M, Dagnew M, et al. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. BMC Infect Dis. 2017;17:219. doi:10.1186/s12879-017-2323-y28320336
- Musa MB, Adamu LA, Galadanci AN, Zubayr B, Odoh NC, Aliyu HM. Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. PLoS One. 2017;12(9):e0185105. doi:10.1371/journal.pone.018510528945771
- Asgedom WS, Teweldemedhin M, Gebreyesus H. Prevalence of multidrug-resistant tuberculosis and associated factors in Ethiopia: a systematic review. Hindawi. 2018;2018:8. doi:10.1155/2018/7104921
- World Health Organization. The End TB Strategy, Global Strategy and Targets for Tuberculosis Prevention, Care and Control After 2015. sixty seventh world health assembly; 2014.
- Federal democratic republic of Ethiopia ministry of health. Guidelines for Clinical and Programmatic Management of TB, TB/HIV and Leprosy in Ethiopia Six Edition. Ethiopia federal ministry of health; 2016.
- Federal Democratic Republic of Ethiopia Ministry of Health. Federal Democratic Republic of Ethiopia Guidelines on Programmatic Management of Drug Resistant Tuberculosis. Addis Ababa, Ethiopia; 2013.
- Tao N, He X, Zhang X, Liu Y, Yu C, Li H. Trends and characteristics of drug-resistant tuberculosis in rural. Int J Infect Dis. 2017;65(2017):8–14. doi:10.1016/j.ijid.2017.09.01928958922
- He X, Zhang X, Zhao J, et al. Epidemiological trends of drug-resistant tuberculosis in China from 2007 to 2014. A retrospective study. Med J. 2016;95(15):e3336. doi:10.1097/MD.0000000000003336
- Randall R, Angelo S. As Ethiopia Moves Toward Tuberculosis Elimination, Success Requires Higher Investment, a Report of the CSIS Global Health Policy Center. Washington, DC: Center for Strategic & International Studies; 2016.
- Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G. Diseases multidrug-resistant mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia. Int J Infect Dis. 2015;39(2015):57–61. doi:10.1016/j.ijid.2015.08.01326327121
- Bollela VR, Puga FG, Moya MJ, Andrea M, Oliveira MD. A decade trend of multidrug resistant tuberculosis in Sao Paulo state, Brazil. Rev Inst Med Trop. 2016;58:77. doi:10.1590/S1678-9946201658077
- Shah MA, Shah BR, Dave NP. Factors contributing to development of multidrug-resistant tuberculosis. Natl J Physiol Pharm Pharmacol. 2018;8(10):1463–1469. doi:10.5455/njppp.2018.8.0826230082018
- Biadglegne F, Sack U, Rodloff CA. Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care. Antimicrob Resist Infect Control. 2014;3:31. doi:10.1186/2047-2994-3-3125685333